Neogen (NEOG) Cash & Equivalents (2010 - 2026)

Neogen has reported Cash & Equivalents for 17 years, with the latest figure at $159.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 25.21% year-over-year to $159.9 million; the trailing twelve-month figure through Feb 2026 stood at $159.9 million (up 25.21% YoY), and the FY2025 full-year result was $129.0 million, down 24.39% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $159.9 million, up from $145.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $205.8 million in Q4 2023, with the low at $42.9 million in Q1 2022.
• Average Cash & Equivalents over 5 years is $129.6 million, with a median of $138.9 million recorded in 2025.
• Year-over-year, Cash & Equivalents plunged 41.65% in 2022 and soared 267.05% in 2023.
• Tracing NEOG's Cash & Equivalents over 5 years: stood at $100.0 million in 2022, then jumped by 105.76% to $205.8 million in 2023, then slumped by 31.85% to $140.2 million in 2024, then grew by 3.64% to $145.3 million in 2025, then advanced by 10.02% to $159.9 million in 2026.
• The last three Cash & Equivalents figures came in at $159.9 million (Q1 2026), $145.3 million (Q4 2025), and $138.9 million (Q3 2025), per Business Quant data.

Peer Comparison